Patent opinions from the Eastern District of Texas and the U.S. Court of Appeals for the Federal Circuit

Fed. Cir.

Classen Immunotherapies, Inc. v. Somaxon Pharmaceuticals, No. 13-1405 (Fed. Cir. Jan. 17, 2014)

Affirmed
Court
U.S. Court of Appeals for the Federal Circuit
Case No.
No. 13-1405
Decided
January 17, 2014
Judge
Per curiam (Rule 36)
Document
Rule 36 Judgment
Length
2 pages

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

OF THE COURT January 17, 2014 /s/ Daniel E. O’Toole Date Daniel E. O’Toole Clerk of Court